Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis
2017
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis
2015
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
2011
Elastography in Clinical Practice
2014
Hepato‐biliary late effects in survivors of childhood and adolescent cancer: A report from the Children's Oncology Group
2009
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Ultrasound elastography: liver
2015
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
2016
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD )
2022
Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography—Analysis of a cohort of 1031 subjects
2013
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2019
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
2016
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
2005 Standout
Hepatic Fibrosis: Prospective Comparison of MR Elastography and US Shear-Wave Elastography for Evaluation
2014
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery
2021
Hepatocellular carcinoma
2012 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Effects of iron overload on chronic metabolic diseases
2014
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
2015
Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage
2014
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Non-alcoholic fatty liver disease
2021 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®
2011
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
2013
An update on the management of acute esophageal variceal bleeding
2016
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation
2011
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
2018
Epidemiology and natural history of non-alcoholic fatty liver disease
2016
Haemochromatosis
2018
The history of the “natural history” of hepatitis C (1968–2009)
2009
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
2017
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
2014
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
2016
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
2009
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Postsynthetic modification of metal–organic frameworks
2009 Standout
Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
2016
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma
2012
Design and synthesis of metal–organic frameworks using metal–organic polyhedra as supermolecular building blocks
2009 Standout
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease
2016
Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath
2012
NAFLD: A multisystem disease
2015 Standout
Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations
2015
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Highly Selective Binding of Organometallic Ruthenium Ethylenediamine Complexes to Nucleic Acids: Novel Recognition Mechanisms
2002
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Solvent-Dependent Formation of Di- and Trinuclear Rhodium and Iridium Complexes Bridged by N, N′-Donor Ligands
2002 StandoutNobel
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
2014
N-Porphyrinylamino and -amido Compounds by Addition of an Amino or Amido Nitrogen to a Porphyrin Meso Position
2000
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
2015
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
2017
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
How I treat hemochromatosis
2010
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features.
2016
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Iron-Deficiency Anemia
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Nonalcoholic fatty liver disease
2015
An update on the management of acute esophageal variceal bleeding
2017
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: The Edinburgh type 2 diabetes study
2013
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
2013
One-dimensional coordination polymers: Applications to material science
1993
Tumor biology and pre‐transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
2013
Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease
2012
Health Behaviors, Medical Care, and Interventions to Promote Healthy Living in the Childhood Cancer Survivor Study Cohort
2009
Yield of Screening for Long-Term Complications Using the Children's Oncology Group Long-Term Follow-Up Guidelines
2012
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications
2016 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Engineering coordination polymers towards applications
2003 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques
2015
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
2019
Works of Mark Levstik being referenced
Meta‐analysis: vasoactive medications for the management of acute variceal bleeds
2012
Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease
2013
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe
2011
Feasibility and Diagnostic Performance of the Fibroscan XL Probe for Liver Stiffness Measurement in Overweight and Obese Patients
2011
Recurrent Hepatocellular Carcinoma After Transplantation
2007
Five- and six-coordinate high-spin iron(III) porphyrin complexes with teflate (OTeF5-) ligands
1989
Eligibility and Exclusion of Hemochromatosis Patients as Voluntary Blood Donors
1998
Comparison of variable-temperature proton NMR spectra of five-coordinate high-spin (S = 5/2) iron(III) porphyrins and chlorins
1988
The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort
2003
Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre.
2010
Should a Lower Quality Organ Go to the Least Sick Patient? Model for End-Stage Liver Disease Score and Donor Risk Index as Predictors of Early Allograft Dysfunction
2012
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
2012